Immunexpress

Immunexpress

Biotechnology, 425 Pontius Ave N Ste 470, Seattle, Washington, 98109, United States, 11-50 Employees

immunexpress.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 12*********

Who is IMMUNEXPRESS

Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product ...

Read More

map
  • 425 Pontius Ave N Ste 470, Seattle, Washington, 98109, United States Headquarters: 425 Pontius Ave N Ste 470, Seattle, Washington, 98109, United States
  • 2006 Date Founded: 2006
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from IMMUNEXPRESS

Immunexpress Org Chart and Mapping

Employees

Carol Whisenant

Office Manager and Executive Assistant

Jane Papadaki

VP of Market Development & Commercial Operations

Silvia Cermelli

Director of Clinical Operations

Roy Davis

Chief Medical Officer

Roz Brandon

Non Executive Director

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Immunexpress

Answer: Immunexpress's headquarters are located at 425 Pontius Ave N Ste 470, Seattle, Washington, 98109, United States

Answer: Immunexpress's phone number is 12*********

Answer: Immunexpress's official website is https://immunexpress.com

Answer: Immunexpress's revenue is $1 Million to $5 Million

Answer: Immunexpress's SIC: 8731

Answer: Immunexpress's NAICS: 541714

Answer: Immunexpress has 11-50 employees

Answer: Immunexpress is in Biotechnology

Answer: Immunexpress contact info: Phone number: 12********* Website: https://immunexpress.com

Answer: Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems. Unlike the traditional approach to sepsis diagnosis, SeptiCyte quantifies the specific molecular biomarkers from a patient's immune system ('host response'). Biomarkers capture signals from a patient's immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access